Links	Protein Name	Symbol	Alternate Names	# of Sites	# of Antibodies
	14-3-3 beta	YWHAB	14-3-3 beta; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta; 14-3-3 alpha;	1	1
	14-3-3 epsilon	YWHAE	14-3-3 epsilon; 14-3-3E; protein kinase C inhibitor protein-1; PKC inhibitor protein-1; mitochondrial import stimulation factor L subunit; mt import stimulation factor L subunit; KCIP-1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide;	1	1
	14-3-3 eta	YWHAH	14-3-3 eta; PROTEIN KINASE C INHIBITOR PROTEIN-1; KCIP-1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta;	1	1
	14-3-3 gamma	YWHAG	14-3-3 gamma; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma;	1	1
	14-3-3 zeta	YWHAZ	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; 14-3-3 zeta; 14-3-3 delta;	1	1
	4E-BP1	EIF4EBP1	eukaryotic translation initiation factor 4E binding protein 1; 4E-BP1; phosphorylated heat- and acid-stable protein; PHAS-1;	5	13
	53BP1	TP53BP1	tumor protein 53-binding protein 1; 53bp1;	3	5
	5-lipoxygenase	ALOX5	arachidonate 5-lipoxygenase; 5-LO;	1	1
	abl1	ABL1	abelson strain of murine leukemia viral oncogene homolog 1; abl1; c-abl; abl; p150;	3	8
	Acetyl-CoA Carboxylase	ACACA	acetyl-CoA carboxylase; abll;	1	2
	Actopaxin	PARVA	parvin alpha; Actopaxin;	1	2
	AFX	MLLT7	AFX; forkhead box O4; FOXO4; myeloid/lymphoid or mixed-lineage leukemia translocated to 7; MLLT7;	2	2
	AIP4	ITCH	atrophin-1 interacting protein 4; itchy homolog E3 ubiquitin protein ligase; ITCH;	1	1
	Akt1	AKT1	protein Kinase B; PKB; Akt1; AKT; C-AKT; RAC-alpha serine/threonine kinase; RAC; rac alpha; rac-pk alpha;	3	25
	Akt2	AKT2	Akt2; rac pk beta; racb;	2	3
	AKT3	AKT3	AKT3; protein kinase B gamma; PKBgamma;	2	3
	alpha adducin	ADD1	alpha adducin;	2	3
	alpha B crystallin	CRYAB	alpha B crystallin;	2	3
	alpha filamin	FLNA	alpha-filamin; actin-binding protein-280; ABP-280; filamin-1;	1	1
	alpha synuclein	SNCA	alpha synuclein; non-A-beta component of Alzheimer disease amyloid precursor; NACP;	2	2
	AMPK alpha 1	PRKAA1	AMP-activated protein kinase alpha 1; AMPKalpha-1;	2	7
	AMPK alpha 2	PRKAA2	AMP-activated protein kinase alpha 2;	2	6
	AMPK beta 1	PRKAB1	AMP-activated protein kinase beta 1;	2	3
	androgen receptor	AR	androgen receptor; AR;	2	2
	APC1	ANAPC1	anaphase-promoting complex 1;	2	2
	APC6	CDC16	Anaphase promoting complex 6; cdc16 homolog;	1	1
	APP	APP	amyloid beta (A4) precursor protein; APP;	1	2
	A-Raf	ARAF1	A-Raf;	1	1
	AS160	TBC1D4	TBC1 domain family, member 4; TBC1D4;	1	1
	ASAP1	DDEF1	development and differentiation enhancing factor 1; DDEF1; ASAP1;	1	1
	ASK-1	MAP3K5	MEKK5; Apoptosis signal-regulating kinase 1; ASK-1; ASK; MAPKKK5; MAP3K5;	3	4
	ATF2	ATF2	activating transcription factor 2; ATF2; cAMP-response element-binding protein-2; CRE-BP2;	5	15
	ATM	ATM	ataxia-telangiectasia mutated; ATM; ATM kinase;	1	4
	ATP citrate lyase	ACLY	ATP citrate lyase; ATP-citrate (pro-S-)-lyase; Citrate cleavage enzyme;	1	1
	ATR	ATR	ataxia telangiectasia and Rad3 related; ATR;	1	1
	Aurora A	STK6	serine/threonine kinase 15; STK15; BTAK; Aurora-A kinase; Aurora A; STK6;	1	1
	B23	NPM1	NUCLEOPHOSMIN; NPM; B23; numatrin;	1	1
	bad	BAD	Bcl-2-antagonist of cell death; Bcl-2 binding component 6;	4	14
	B-ATF	BATF	basic leucine zipper transcription factor, ATF-like; BATF1; SFA-2;	2	3
	Bcl-2	BCL2	B cell leukemia 2; Bcl-2; B cell lymphoma 2;	4	6
	bcl-3	BCL3	B cell lymphoma 3; B cell leukemia 3;	2	2
	Bcl-XL	BCL2L1	Bcl-XL; BCL2-like 1;	1	2
	BCR	BCR	breakpoint cluster region; BCR;	1	3
	beta-1 integrin	ITGB1	CD29; GP; ITGB1; Platelet GPIIa; Integrin VLA-4 beta subunit; VLA-beta chain; fibronectin receptor beta subunit; FNRB;	3	3
	beta2-adrenergic receptor	ADRB2	beta2-adrenergic receptor; beta 2-AR;	7	9
	beta-3 integrin	ITGB3	CD61; platelet glycoprotein IIIa; GPIIb/IIIa; GP3A; antigen CD61; CD61A;	2	5
	beta-4 integrin	ITGB4	CD104; beta 4 integrin chain; tumor specific protein 180 antigen; TSP-1180;	2	2
	beta-adducin	ADD2	beta adducin;	1	2
	beta-arrestin1	ARRB1	beta-arrestin1; BArrestin1;	1	4
	beta-catenin	CTNNB1	beta catenin;	7	15
	beta-dystroglycan	DAG1	beta-dystroglycan; beta-DG; dystrophin-associated glycoprotein 1; DAG1; 156DAG; A2; alpha dystroglycan;	1	2
	BID	Bid		2	2
	BIM EL isoform	BCL2L11	Bcl-2 interacting mediator;	2	3
	blnk	BLNK	B cell linker protein; blnk; slp-65;	2	4
	B-Myb	MYBL2	v-myb myeloblastosis viral oncogene homolog (avian)-like 2;	4	4
	B-Raf	BRAF	B-Raf; BRAF; Raf-B1; B-Raf1; RMIL serine/threonine-protein kinase;	3	3
	BRCA1	BRCA1	breast cancer type 1; BRCA1;	9	12
	Btk	BTK	Bruton's tyrosine kinase; Btk; B-cell progenitor kinase; bpk; agammaglobulinemia tyrosine kinase; atk;	2	3
	C/EBP alpha	CEBPA	CCAAT/enhancer binding protein alpha; C/EBP alpha;	3	3
	C/EBP beta	CEBPB	CCAAT/enhancer binding protein beta; C/EBP beta;	1	1
	C3G	RAPGEF1	CRK SH3 domain-binding guanine nucleotide-releasing factor;	1	1
	CAD	CAD	carbamoyl-phosphate synthetase 2; PYR1;	1	1
	caldesmon 1	CALD1	caldesmon 1; caldesmon; NAG22;	2	2
	calmodulin 1	CALM1	calmodulin 1;	6	7
	Calponin 1	CNN1	basic calponin; smooth muscle calponin;	1	1
	CAMK I	CAMK1	calcium/calmodulin-dependent protein kinase I; CAMK I;	1	1
	CAMKII alpha	CAMK2A	calcium/calmodulin-dependent protein kinase II alpha;	2	6
	CAMKII beta	CAMK2B	calcium/calmodulin-dependent protein kinase II beta; CAMKII beta;	2	4
	CAMKII delta	CAMK2D	calcium/calmodulin-dependent protein kinase II delta; CAMKII delta;	2	4
	CAMKII gamma	CAMK2G	calcium/calmodulin-dependent protein kinase II gamma; CAMKII gamma;	2	4
	CAMKIV	CAMK4	calcium/calmodulin-dependent protein kinase IV; CAMK IV;	1	1
	caspase-9	CASP9	caspase-9; apoptotic protease activating factor 3; APAF-3;	2	2
	caveolin-1	CAV1	caveolin-1; VIP21; caveolin;	1	3
	caveolin-2	CAV2	caveolin-2;	1	1
	CB1	CNR1	CB1 cannabinoid receptor; CANN6; CB1K5; CNR;	1	1
	cbl	CBL	cbl; p120 cbl; c-Cbl;	3	6
	CD130	IL6ST	CD130; IL-6R-gp130SIG; IL-6R beta; IL-6ST; gp130;	1	4
	CD131	CSF2RB	CD131; CDw131; common beta subunit; IL-3RB; IL-3Rbeta; IL-5RB; IL-5Rbeta; CSF2RB; CSF-2Rbeta;	1	1
	CD19	CD19	CD19; B4;	1	1
	CD22	CD22	CD22; BL-CAM; Lyb8;	3	3
	CD246	ALK	anaplastic lymphoma kinase 1; alk1; Ki-1; CD246;	2	2
	CD32B	FCGR2B	Fcgamma receptor IIB; FcgammaRIIb; CD32B;	1	1
	CD45	PTPRC	CD45; B220; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; EC 3.1.3.4; Leukocyte Common Antigen; LCA; T200; Ly5;	1	1
	CDC25C	CDC25C	cell division cycle 25C; CDC25C;	3	6
	cdc27	CDC27	cdc27;	1	1
	cdc42	CDC42	cdc42 homolog; cdc42; G25K GTP-BINDING PROTEIN, PLACENTAL ISOFORM; GP; CLA4;	1	2
	cdc6	CDC6	cdc6;	2	2
	cdk1	CDC2	cyclin-dependent kinase 1; CDK1; cell division control protein 2 homolog; cdc2; p34 protein kinase;	3	10
	cdk2	CDK2	cell division protein kinase 2; CDK2; p33;	2	2
	CENP-A	CENPA	centromere protein A; CENP-A;	1	2
	c-Fos	FOS	cell FBJ murine osteosarcoma; fos;	2	2
	Chk1	CHEK1	Checkpoint kinase; Chk1;	4	7
	Chk2	CHEK2	Chk2; Rad53;	7	9
	CKII beta	CSNK2B	Casein kinase II beta; CK2b;	1	1
	c-Kit	KIT	CD117; stem cell factor receptor; SCFR;	7	14
	c-myb	MYB	v-myb avian myeloblastosis viral oncogene homolog; myb; efg;	2	2
	c-myc	MYC	c-myc;	2	6
	cofilin 1	CFL1	cofilin 1; cofilin non-muscle isoform;	1	3
	cofilin 2	CFL2	cofilin 2; cofilin muscle isoform;	1	1
	connexin 43	GJA1	connexin 43;	1	2
	COT	MAP3K8	cancer osaka thyroid oncogene; cCOT; MEKK8; Tpl-2; mitogen-activated protein kinase kinase kinase 8; MAP3K8;	1	1
	CPI-17	PPP1R14A	CPI-17;	1	1
	cPLA2-alpha	PLA2G4A	cPLA2-alpha; PLA2 IVA;	1	1
	c-Raf	RAF1	c-Raf; raf-1; mil; Raf1;	10	22
	CREB-alpha	CREB1	cyclic AMP response element binding protein 1; CREB; CREB 1;	2	11
	CREB-delta	CREB1	cyclic AMP response element binding protein 1; CREB; CREB 1;	2	11
	c-Ret	RET	ret proto-oncogene; Ret;	3	3
	Crk	CRK	Crk; c-Crk;	1	1